Thomas A Moore Net Worth & Insider Trades

Thomas A Moore Advaxis, Inc

As of July 18, 2014

What is Thomas A Moore's Net Worth?

The current estimated net worth of Advaxis, Inc's Thomas A Moore is estimated to be about $12.96M . Thomas A Moore owns about 0 unit of Advaxis, Inc common stock. In the last 8 years at Advaxis, Inc, Thomas A Moore has sold an estimated value of $0 worth.

What is Thomas A Moore's Past Insider Trading?

Thomas A Moore's largest purchase order was 2,666,667 units , worth over $400K on October 26, 2007. In total, Thomas A Moore has made about 16 transactions over 8 years of their time at Advaxis, Inc. Thomas A Moore usually trades in July, with the busiest year in 2012, 2011 and 2010. The most recent transaction was a purchase order of 0 unit , worth over $0 on August 31, 2011.

Thomas A Moore

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Thomas A Moore's' Mailing Address?

  • Mailing address is 305 College Road East Princeton NJ 08450 NJ

Advaxis, Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Compensation
Total
Kenneth Berlin 2020 $554,320 $554,320 - $26,000 $53,809 $1,188,449
Kenneth Berlin 2019 $551,750 $240,000 - $146,398 $45,588 $983,736
Molly Henderson 2020 $369,163 - - $26,000 $18,593 $413,756
Molly Henderson 2019 $397,896 $120,000 - $58,498 $20,052 $596,446
Andres Gutierrez 2020 $426,130 $170,560 - $26,000 $27,575 $650,265
Andres Gutierrez 2019 $424,423 $120,000 - $58,498 $24,346 $627,267
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1100397/000149315221009377/def14a.htm

What are Advaxis, Inc's Past Insider Trades?

Advaxis, Inc's most recent insider trade came on March 16, 2020 by Roni Appel who sold 3,000 units worth $1.7K . In the last 13 years, insiders at Advaxis, Inc have sold an estimated value of $11.98M and bought an estimated value of $21.93M worth of shares. Insider trading is most common in November, with the busiest year in 2015. The most active traders at the company are Robert Petit, Chief Scientific Officer,  Sara Bonstein, Chief Financial Officer,  and Daniel O'Connor, Chief Executive Officer .

Ayala Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...